India has set a target of building a biotech industry worth $100 billion by 2025.
The Department of Biotechnology (DBT), part of India’s Ministry of Science and Technology, met recently to discuss a roadmap for delivering on the goal and to support initiatives that can make a positive social impact. At the heart of the strategy is a commitment to advancing projects that improve the lives of the underprivileged. And the DBT meeting agreed that such initiatives should be rewarded.
One of the priorities identified by the DBT is to remove regulatory hurdles and the country has already shown its intent. India’s environment ministry recommended this month that a genetically-modified (GM) mustard crop developed by the University of Delhi is given the go-ahead, paving the way for its first ever commercially produced GM crop.